Renal cell carcinoma.

Abstract:

:Renal cell carcinoma remains a devastating disease known for insidious onset, with patients often having advanced incurable disease at the time of diagnosis. Biologic therapy with IL-2 offers a chance for prolonged remission for a minority of patients, but its toxicities preclude most patients from ever receiving it. Preclinical experiments and early results of novel clinical trials based on the latest theories in molecular oncology and immunology are leading to promising new treatments for this disease.

journal_name

Curr Opin Oncol

authors

Savage PD

doi

10.1097/00001622-199505000-00013

subject

Has Abstract

pub_date

1995-05-01 00:00:00

pages

275-80

issue

3

eissn

1040-8746

issn

1531-703X

journal_volume

7

pub_type

杂志文章,评审
  • Three molecular determinants of malignant conversion and their potential as therapeutic targets.

    abstract::The past decade has been marked by an explosion of knowledge regarding the dysregulation of cancer at the molecular level. It has become apparent that oncogenes, tumor suppressor genes, and other ancillary molecules interact in complex pathways that govern cellular homeostasis. We review three molecular events that ha...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199901000-00013

    authors: Dome JS,Look AT

    更新日期:1999-01-01 00:00:00

  • State-of-the-art in the management of locally advanced and metastatic gallbladder cancer.

    abstract:PURPOSE OF REVIEW:Gallbladder carcinoma (GBC), classified as a biliary tract cancer (BTC) along with intrahepatic and extrahepatic cholangiocarcinomas, is a rare disease in Western countries, but a highly prevalent disease in Chile, other countries in Latin America, India and Japan. It commonly presents at an advanced ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3283620fd8

    authors: McNamara MG,Metran-Nascente C,Knox JJ

    更新日期:2013-07-01 00:00:00

  • Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck cancer.

    abstract::Tyrosine kinase (type 1) growth factor receptors include the erbB family. These cell surface receptors were discovered in the context of cellular transformation and have subsequently been found to be overexpressed in many types of human cancer. Cumulative evidence suggests that upregulation of the most well-characteri...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200105000-00007

    authors: Lango MN,Shin DM,Grandis JR

    更新日期:2001-05-01 00:00:00

  • State-of-the-art of bone marrow imaging in multiple myeloma.

    abstract:PURPOSE OF REVIEW:Multiple myeloma is a common hematological malignancy arising in the bone marrow. Bone lesions were initially depicted with conventional radiography, although recently F-FDG PET/CT and MRI are recognized as having a clear role in the initial workup and in the evaluation of therapy response. RECENT FI...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000230

    authors: Martí-Bonmatí L,Ramirez-Fuentes C,Alberich-Bayarri Á,Ruiz-Llorca C

    更新日期:2015-11-01 00:00:00

  • Molecular genetic markers as predictors of response to chemotherapy in gliomas.

    abstract:PURPOSE OF REVIEW:This review summarizes recent studies on applications of molecular markers such as chromosome 1p/19q codeletion and MGMT status in the treatment of glioma. RECENT FINDINGS:Prospective trials confirmed that 1p/19q codeletion represents a strong and independent favourable prognostic factor in anaplasti...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3282f075f3

    authors: Idbaih A,Omuro A,Ducray F,Hoang-Xuan K

    更新日期:2007-11-01 00:00:00

  • Circulating tumor markers in gynecological tumors.

    abstract::The correct use of tumor markers in patients with gynecological cancers can make an impact on management of the disease. Their value in screening for ovarian cancer cannot be recommended outside trials. Increased levels of various markers give prognostic information that could alter therapy for patients with early ova...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199609000-00015

    authors: Rustin GJ

    更新日期:1996-09-01 00:00:00

  • Targeting angiogenesis for the treatment of sarcoma.

    abstract:PURPOSE OF REVIEW:More therapeutic options are needed for bone and soft tissue sarcomas, especially for patients with metastatic disease. Recent randomized clinical trials conducted in colon, breast and lung cancer have shown the anti-vascular endothelial growth factor agent, bevacizumab, alone or in combination with c...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000228741.64541.ca

    authors: Balasubramanian L,Evens AM

    更新日期:2006-07-01 00:00:00

  • Renal cell carcinoma.

    abstract:PURPOSE OF REVIEW:The recent contributions to renal cell carcinoma in the fields of molecular biology and the expanded use of molecularly targeted agents will be reviewed. This study is intended to update prognostic and therapeutic decision-making data and provide perspective on advances in understanding the molecular ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3282f9782b

    authors: Rini BI,Rathmell WK,Godley P

    更新日期:2008-05-01 00:00:00

  • Bronchoscopic invasive diagnostic techniques in the cancer patient.

    abstract::The cancer patient often presents with fever and pulmonary infiltrates, in particular during the course of chemotherapy or after bone marrow transplantation. In these conditions, specific diagnoses are mainly related to an infective cause, but noninfectious processes, malignant or not, are also found alone or in combi...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章

    doi:10.1097/00001622-200107000-00005

    authors: Ninane V

    更新日期:2001-07-01 00:00:00

  • Chemotherapy for malignant pleural mesothelioma.

    abstract::This paper covers the outcome of previously conducted clinical trials on chemotherapy for malignant pleural mesothelioma and presents data from recent phase II and phase III trials. In contrast to conventional cytotoxic drugs, which have barely produced response rates exceeding 30%, recently introduced chemotherapeuti...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200303000-00006

    authors: Tomek S,Manegold C

    更新日期:2003-03-01 00:00:00

  • Testicular cancer.

    abstract::In testicular cancer epidemiology, the increasing recognition that germinal epithelial atrophy is the final common pathway in the development of this tumor has developed along with reports that elevated follicule-stimulating hormone levels at the time of diagnosis of first tumor correlate with risk of developing a sec...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Oliver RT

    更新日期:1991-06-01 00:00:00

  • Pralatrexate: an emerging new agent with activity in T-cell lymphomas.

    abstract:PURPOSE OF REVIEW:T-cell lymphomas (TCL) represent a particularly poor prognosis subgroup of lymphomas. The goal of this review is to provide emerging information on one agent demonstrating activity in these challenging diseases. Pralatrexate is a novel antifolate designed to have high affinity for the reduced folate c...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000245309.74767.20

    authors: O'Connor OA

    更新日期:2006-11-01 00:00:00

  • Molecular prediction of metastasis in cutaneous squamous cell carcinoma.

    abstract:PURPOSE OF REVIEW:Cutaneous squamous cell carcinoma (cSCC) is a highly prevalent malignancy frequently occurring on body surfaces chronically exposed to ultraviolet radiation. While a large majority of tumors remain localized to the skin and immediate subcutaneous tissue and are cured with surgical excision, a small su...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000609

    authors: Mulvaney PM,Schmults CD

    更新日期:2020-03-01 00:00:00

  • Graft-versus-host disease.

    abstract::Graft-versus-host disease (GVHD) continues to be a major obstacle to the success of allogeneic bone marrow transplantation. Furthermore, several clinical strategies being employed at this time in the field of bone marrow transplantation have had an impact on GVHD. In addition to the usual division of topics such as pa...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199703000-00005

    authors: Marcellus DC,Vogelsang GB

    更新日期:1997-03-01 00:00:00

  • Chondrosarcoma and other rare bone sarcomas.

    abstract::The clinical staging of bone tumors, even rare ones, has been much improved with the availability of better imaging techniques. Once diagnosis of a rare bone tumor has been made, close consultation between clinician, radiologist, and pathologist is essential for optimal treatment. Recent advances in the staging proced...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Dirix LY,Van Oosterom AT

    更新日期:1991-08-01 00:00:00

  • Tumor microenvironment in mycosis fungoides and Sézary syndrome.

    abstract:PURPOSE OF REVIEW:Mycosis fungoides and Sézary syndrome arise from malignant T cells that reside in skin, and subsequently are capable of circulating between skin, lymph nodes, and blood. The pathophysiologic mechanisms that cause and result in different behaviors of the skin-homing-malignant T cells in different stage...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000243

    authors: Rubio Gonzalez B,Zain J,Rosen ST,Querfeld C

    更新日期:2016-01-01 00:00:00

  • Neuroendocrine tumors of the diffuse neuroendocrine system.

    abstract:PURPOSE OF REVIEW:Neuroendocrine tumors (previously referred to as carcinoids) are ill-understood, enigmatic malignancies that, although slow-growing compared with adenocarcinomas, can behave aggressively. In 2004, they comprised 1.25% of all malignancies; their incidence is increasing by approximately 6% per year. The...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3282f1c595

    authors: Gustafsson BI,Kidd M,Modlin IM

    更新日期:2008-01-01 00:00:00

  • The emerging role of immunotherapy in advanced urothelial cancers.

    abstract:PURPOSE OF REVIEW:Recent Food and Drug Administration (FDA) approval of five new immune checkpoint inhibitors for the treatment of metastatic urothelial cancer represents the first major treatment breakthrough for this disease since the introduction of combination chemotherapy over 30 years ago. This review examines th...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000445

    authors: Tabayoyong W,Gao J

    更新日期:2018-05-01 00:00:00

  • Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma.

    abstract:PURPOSE OF REVIEW:Melanoma has proven resistant to most available chemotherapy and immunotherapy. Despite a range of different biochemical targets, most agents kill cancer cells by induction of apoptosis. RECENT FINDINGS:Investigation of this process has provided insights into the resistance mechanisms in cancer cells...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000208794.24228.9f

    authors: Hersey P

    更新日期:2006-03-01 00:00:00

  • Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach.

    abstract::The vast majority of adults with acute lymphoblastic leukemia (ALL) now achieve remission with current intensive chemotherapy regimens. Nevertheless, most adults with ALL will eventually relapse and die of their disease. Specific clinical and molecular-cytogenetic prognostic factors have been identified that are begin...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200101000-00004

    authors: Verma A,Stock W

    更新日期:2001-01-01 00:00:00

  • Modern treatment approaches for Hodgkin's disease.

    abstract::Recent studies are refining the treatment approaches of radiation therapy and combination chemotherapy in Hodgkin's disease. In early-stage disease, attempts are being made to lessen the toxicity of treatment while maintaining excellent results. Optimal results are achieved in advanced disease with combined radiation ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199309000-00003

    authors: Straus DJ

    更新日期:1993-09-01 00:00:00

  • Pathogenesis of human immunodeficiency virus-related Kaposi's sarcoma.

    abstract::Infection with the human immunodeficiency virus-1 is associated with a marked increase in the incidence of Kaposi's sarcoma. Recent studies suggest that the risk of Kaposi's sarcoma in human immunodeficiency virus infection is increased with oral-fecal contact and that a sexually transmitted agent possibly related to ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199210000-00010

    authors: Miles SA

    更新日期:1992-10-01 00:00:00

  • Can we define the optimal sequence of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of epidermal growth factor receptor-mutant nonsmall cell lung cancer?

    abstract:PURPOSE OF REVIEW:The most common mechanism of resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is acquisition of the T790M gatekeeper mutation. Third-generation EGFR TKIs irreversibly inhibit EGFR mutants (EGFRm), especially T790M, while sparing wild-type EGFR. There are several ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000350

    authors: Sun JM,Park K

    更新日期:2017-03-01 00:00:00

  • Role of the unfolded protein response in tumor cell characteristics and cancer outcome.

    abstract:PURPOSE OF REVIEW:In the present review, we discuss the possible role of the unfolded protein response (UPR) in the acquisition of tumor cell characteristics and in the prognosis of cancer outcome, which could assist and contribute to the development of more promising therapeutic strategies. RECENT FINDINGS:Accumulati...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000339

    authors: Galmiche A,Sauzay C,Chevet E,Pluquet O

    更新日期:2017-01-01 00:00:00

  • Neurological paraneoplastic syndromes: an update.

    abstract:PURPOSE OF REVIEW:To describe recent advances in the diagnosis and treatment of paraneoplastic neurological syndromes (PNS). RECENT FINDINGS:PNS are rare complications of cancer caused by an immune cross-reaction between antigens expressed by tumor cells and neurons. The target of the immune attack can be an intracell...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000479

    authors: Berzero G,Psimaras D

    更新日期:2018-11-01 00:00:00

  • Clear cell cancer of the ovary.

    abstract:PURPOSE OF REVIEW:Recent discoveries have demonstrated that ovarian cancer is actually composed of multiple separate diseases. Clear cell cancer is an important example. This review will describe the unique biology of clear cell carcinoma, its novel molecular features, and the recent translation of this into new therap...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328363e0c7

    authors: Penson RT,Dizon DS,Birrer MJ

    更新日期:2013-09-01 00:00:00

  • Respiratory syncytial virus and other respiratory viruses in the setting of bone marrow transplantation.

    abstract:PURPOSE OF REVIEW:Several epidemiologic studies have enhanced our understanding of the impact of respiratory viruses on bone marrow transplant recipients. RECENT FINDINGS:Respiratory viral infections occur frequently following stem cell transplantation but present atypically. Many patients have asymptomatic infections...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328324bc1c

    authors: Ison MG

    更新日期:2009-03-01 00:00:00

  • Thyroid nodules: diagnosis and therapy.

    abstract::Less than 1% of all cancers are present in the thyroid, yet thyroid nodules are found in 4 to 10% of the adult population. Because thyroid nodules are relatively common, the diagnostic dilemma is to distinguish between a more common benign nodule, which usually does not require specific treatment, and a malignant nodu...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200201000-00009

    authors: Weiss RE,Lado-Abeal J

    更新日期:2002-01-01 00:00:00

  • Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes.

    abstract:PURPOSE OF REVIEW:Tumor stroma is composed of many cellular subtypes, of which the most abundant are fibroblasts, macrophages and endothelial cells. During the process of tissue injury, these three cellular subtypes must coordinate their activity to efficiently contribute to tissue regeneration. In tumor, this mechanis...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000420

    authors: Ronca R,Van Ginderachter JA,Turtoi A

    更新日期:2018-01-01 00:00:00

  • Use of granulocyte-colony stimulating factors in older patients: a review of recently published data.

    abstract:PURPOSE OF REVIEW:This review presents the analysis of recently published studies about the benefit from granulocyte-colony stimulating factors (G-CSF) in older cancer patients receiving chemotherapy. RECENT FINDINGS:During the last years, no major study aiming to confirm the clinical benefit of G-CSF prophylaxis in o...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000632

    authors: Klastersky JA,Dal Lago L,Lalami Y

    更新日期:2020-07-01 00:00:00